MR Number;Product Name;Domain;Active substances;Pharmaceutical Form;Application Type Level 1;Application Type Level 2;Application Type Level 3;Application Type Level 4;Application Type Level 5;Marketing Authorization Holder;RMS;CMS;Date of outcome;Date of last update;ATC-Code;Strength;SPC Url;Par Url;Final Labelling Url;Final PL Url;Finalised Product Information Url
SE/H/1002/005 ;Ropivakain Sintetica;Human;ropivacaine  10 mg/ml;Solution for injection;Abridged;Additional Strength/Form;Generic;Chemical Substance;Prescription Only;Sintetica Italia srl, Milano, Italy;Sweden;AT - Ropivacain Sintetica 10 mg/ml Injektionslösung, DE - Medunacain 10 mg/ml Injektionslösung, ES, IE, UK;12.05.2011;03.02.2013;N01BB09-Ropivacaine;10mg/ml;http://www.lakemedelsverket.se/SPC_PIL/Pdf/enhumspc/Ropivakain%20Sintetica%2010mgml%20solution%20for%20injection%20ENG.doc;http://www.lakemedelsverket.se/SPC_PIL/Pdf/par/Ropivakain%20Sintetica,%20solution%20for%20injection.pdf;;http://www.lakemedelsverket.se/SPC_PIL/Pdf/enhumpil/Ropivakain%20Sintetica%2010mgml%20solution%20for%20injection%20ENG.doc;